Akebia Therapeutics Newsroom

Piper Sandler Maintains Akebia Therapeutics(AKBA.US) With Buy Rating, Maintains Target Price $4

Moomoo NewsNov 14 07:34 ET

Akebia Therapeutics Analyst Ratings

BenzingaOct 23 07:31 ET

H.C. Wainwright Maintains Akebia Therapeutics(AKBA.US) With Buy Rating, Maintains Target Price $7.5

Moomoo NewsOct 23 06:35 ET

BTIG Maintains Akebia Therapeutics(AKBA.US) With Buy Rating, Maintains Target Price $5

Moomoo NewsOct 11 07:35 ET

Akebia Therapeutics Analyst Ratings

BenzingaOct 10 13:24 ET

H.C. Wainwright Maintains Akebia Therapeutics(AKBA.US) With Buy Rating, Maintains Target Price $7.5

Moomoo NewsOct 8 06:31 ET

Akebia Therapeutics Analyst Ratings

BenzingaSep 6 07:28 ET

H.C. Wainwright Maintains Akebia Therapeutics(AKBA.US) With Buy Rating, Maintains Target Price $7.5

Moomoo NewsSep 6 06:31 ET

Buy Rating Reaffirmed for Akebia Therapeutics Ahead of Vafseo's Market Launch

TipRanksSep 6 06:20 ET

Akebia Therapeutics Analyst Ratings

BenzingaAug 12 07:05 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: GeoVax Labs (GOVX), Akebia Therapeutics (AKBA) and Aveanna Healthcare Holdings (AVAH)

TipRanksAug 9 07:59 ET

Buy Rating Justified by Akebia Therapeutics' Strengthened Dialysis Negotiations and Positive Commercial Prospects

TipRanksJul 12 08:17 ET

Piper Sandler Sticks to Its Buy Rating for Akebia Therapeutics (AKBA)

TipRanksApr 26 07:56 ET

Akebia Therapeutics Analyst Ratings

BenzingaMar 28 12:21 ET

Analysts Offer Insights on Healthcare Companies: Integer Holdings (ITGR), Akebia Therapeutics (AKBA) and Moderna (MRNA)

TipRanksMar 28 07:05 ET

Analysts' Top Healthcare Picks: Verastem (VSTM), Akebia Therapeutics (AKBA)

TipRanksMar 16 12:35 ET

Piper Sandler Remains a Buy on Akebia Therapeutics (AKBA)

TipRanksMar 15 07:11 ET

Buy Rating for Akebia Therapeutics Amid Anticipated Approval of Anemia Drug Vadadustat and Strong Financial Position

TipRanksMar 15 06:31 ET

Akebia Therapeutics Analyst Ratings

BenzingaMar 15 06:28 ET

Optimistic Buy Rating for Akebia Therapeutics Amid Strategic Financial Restructuring and Anticipated FDA Approval

TipRanksJan 31 10:35 ET